| scholarly article | Q13442814 |
| P50 | author | Jeannie T. Lee | Q30068211 |
| Ruslan I Sadreyev | Q59871719 | ||
| David T Scadden | Q88652265 | ||
| P2093 | author name string | James E Kirby | |
| Eda Yildirim | |||
| Diane E Brown | |||
| Francois E Mercier | |||
| P2860 | cites work | YY1 tethers Xist RNA to the inactive X nucleation center | Q24311256 |
| Evidence of Xist RNA-independent initiation of mouse imprinted X-chromosome inactivation | Q24644032 | ||
| XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure | Q24672147 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Summaries of Affymetrix GeneChip probe level data | Q27860888 | ||
| Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome | Q29547359 | ||
| The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus | Q29614336 | ||
| Requirement for Xist in X chromosome inactivation | Q29614509 | ||
| SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells | Q29615006 | ||
| Epigenetic regulation by long noncoding RNAs | Q29618108 | ||
| Gene action in the X-chromosome of the mouse (Mus musculus L.) | Q29618263 | ||
| Two-step imprinted X inactivation: repeat versus genic silencing in the mouse | Q30495292 | ||
| Clinical effect of point mutations in myelodysplastic syndromes | Q33395996 | ||
| Chronic myelomonocytic leukemia terminating as malignant histiocytosis. | Q33450337 | ||
| Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis. | Q33889210 | ||
| A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation | Q33908327 | ||
| The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors | Q34182890 | ||
| Acquired gain of an X chromosome as the sole abnormality in the blast crisis of chronic neutrophilic leukemia | Q34628739 | ||
| X chromosome dosage compensation: how mammals keep the balance | Q34657007 | ||
| GATA Transcription Factors and Cancer | Q34972814 | ||
| Hematopoietic precursor cells transiently reestablish permissiveness for X inactivation | Q35071298 | ||
| Detection of nascent RNA, single-copy DNA and protein localization by immunoFISH in mouse germ cells and preimplantation embryos | Q35105300 | ||
| Loss of the wild-type allele contributes to myeloid expansion and disease aggressiveness in FLT3/ITD knockin mice | Q35525611 | ||
| Novel Perspective: Focusing on the X Chromosome in Reproductive Cancers | Q35553879 | ||
| CancerGenes: a gene selection resource for cancer genome projects | Q35608470 | ||
| Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. | Q35647543 | ||
| Chromatin maintenance by a molecular motor protein | Q35883264 | ||
| The sex chromatin in benign tumours and related conditions in man. | Q36132140 | ||
| Allele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAP | Q36453549 | ||
| X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells | Q36534475 | ||
| X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations | Q36534501 | ||
| Histopathology of the spleen | Q36635915 | ||
| Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes | Q36655275 | ||
| Erosion of dosage compensation impacts human iPSC disease modeling | Q36703082 | ||
| Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach | Q37082740 | ||
| Large non-coding RNAs: missing links in cancer? | Q37781625 | ||
| New mutations and pathogenesis of myeloproliferative neoplasms. | Q37886439 | ||
| Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation | Q37902049 | ||
| Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management | Q37956603 | ||
| Gracefully ageing at 50, X-chromosome inactivation becomes a paradigm for RNA and chromatin control | Q37959726 | ||
| Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions | Q37979958 | ||
| Development of hematopoietic stem cell activity in the mouse embryo | Q38306839 | ||
| Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells | Q38507121 | ||
| Isodicentric (X)(q13) in haematological malignancies: presentation of five new cases, application of fluorescence in situ hybridization (FISH) and review of the literature | Q38508173 | ||
| Perinucleolar targeting of the inactive X during S phase: evidence for a role in the maintenance of silencing. | Q40130925 | ||
| In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells | Q41589782 | ||
| Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. | Q46455047 | ||
| The idic(X)(q13) in myeloid malignancies: breakpoint clustering in segmental duplications and association with TET2 mutations. | Q53180267 | ||
| Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms. | Q54518446 | ||
| The human X-inactivation centre is not required for maintenance of X-chromosome inactivation | Q59073076 | ||
| Absence of the XIST gene from late-replicating isodicentric X chromosomes in leukaemia | Q60641474 | ||
| Male breast cancer | Q64046986 | ||
| Twenty-six patients with hematologic disorders and X chromosome abnormalities. Frequent idic(X)(q13) chromosomes and Xq13 anomalies associated with pathologic ringed sideroblasts | Q69746706 | ||
| Competitive repopulation: a new assay for long-term stem cell functional capacity | Q72124567 | ||
| Malignant histiocytosis in the leukaemic stage: a new entity (M5c-AML) in the FAB classification? | Q72290485 | ||
| Xist-deficient mice are defective in dosage compensation but not spermatogenesis | Q73014374 | ||
| Of mice and men: comparison of the ultrastructure of megakaryocytes and platelets | Q77135889 | ||
| Acquired X-chromosome aneuploidy in children with acute lymphoblastic leukemia | Q77371930 | ||
| Conditional deletion of Xist disrupts histone macroH2A localization but not maintenance of X inactivation | Q78079159 | ||
| Transgenic mice with hematopoietic and lymphoid specific expression of Cre | Q78842092 | ||
| Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin | Q79839234 | ||
| The disappearing Barr body in breast and ovarian cancers | Q80568616 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hematologic cancer | Q18975047 |
| P304 | page(s) | 727-742 | |
| P577 | publication date | 2013-02-01 | |
| P1433 | published in | Cell | Q655814 |
| P1476 | title | Xist RNA is a potent suppressor of hematologic cancer in mice | |
| P478 | volume | 152 |
| Q34041980 | A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer |
| Q47250939 | A mixed modality approach towards Xi reactivation for Rett syndrome and other X-linked disorders. |
| Q90392360 | AFF3-DNA methylation interplay in maintaining the mono-allelic expression pattern of XIST in terminally differentiated cells |
| Q92444544 | Acute Myeloid Leukemia: Aging and Epigenetics |
| Q39400164 | Acute myeloid leukaemia genomics. |
| Q50002288 | Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer. |
| Q37670401 | An Insight into the Increasing Role of LncRNAs in the Pathogenesis of Gliomas |
| Q26865920 | An expanding universe of the non-coding genome in cancer biology |
| Q26829861 | An integrative view on sex differences in brain tumors |
| Q26753467 | An overview of long non-coding RNAs in ovarian cancers |
| Q64055462 | Atractylenolide II reverses the influence of lncRNA XIST/miR-30a-5p/ROR1 axis on chemo-resistance of colorectal cancer cells |
| Q41615645 | Atypical chronic myeloid leukemia with isochromosome (X)(p10): A case report. |
| Q38757074 | Biological and clinical significance of cancer stem cell plasticity |
| Q38765793 | Breast cancer stem cells programs: enter the (non)-code. |
| Q48813459 | CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma. |
| Q47297451 | CRISPR/Cas9-mediated modulation of splicing efficiency reveals short splicing isoform of Xist RNA is sufficient to induce X-chromosome inactivation. |
| Q35770643 | Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation |
| Q34674423 | Cancer-like epigenetic derangements of human pluripotent stem cells and their impact on applications in regeneration and repair |
| Q39446342 | Choosing Cell Fate Through a Dynamic Cell Cycle |
| Q37593671 | Chromatin changes in reprogramming of mammalian somatic cells |
| Q38868008 | Chromosome X genomic and epigenomic aberrations and clinical implications in breast cancer by base resolution profiling |
| Q52652794 | Chromosome-wide gene dosage rebalance may benefit tumor progression. |
| Q34481375 | Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation |
| Q36599564 | Cis- and trans-regulation in X inactivation |
| Q92543510 | Clinical Epigenetic Therapies Disrupt Sex Chromosome Dosage Compensation in Human Female Cells |
| Q54203619 | Clinical utility of circulating non-coding RNAs - an update. |
| Q61803829 | Cold Induced Antisense Transcription of in Distant Grasses |
| Q53685177 | Colon Cancer-Upregulated Long Non-Coding RNA lincDUSP Regulates Cell Cycle Genes and Potentiates Resistance to Apoptosis. |
| Q36014197 | Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer |
| Q26864051 | Common features of chromatin in aging and cancer: cause or coincidence? |
| Q92997623 | Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer |
| Q34326079 | Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications |
| Q37665607 | Comprehensive characterization of lncRNA-mRNA related ceRNA network across 12 major cancers |
| Q34266426 | Coupling of X-chromosome reactivation with the pluripotent stem cell state |
| Q36142411 | DNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer. |
| Q34363848 | Databases for lncRNAs: a comparative evaluation of emerging tools |
| Q36447505 | Dynamic interplay and function of multiple noncoding genes governing X chromosome inactivation |
| Q35152112 | Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma |
| Q28074522 | Emerging concepts of epigenetic dysregulation in hematological malignancies |
| Q47657395 | Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis |
| Q26774949 | Epigenetic Control of Haematopoietic Stem Cell Aging and Its Clinical Implications |
| Q27026054 | Epigenetic regulation of hematopoietic stem cell aging |
| Q38163846 | Epigenetics of myelodysplastic syndromes |
| Q38889708 | Establishment of X chromosome inactivation and epigenomic features of the inactive X depend on cellular contexts |
| Q33890699 | Exploring the stability of long intergenic non-coding RNA in K562 cells by comparative studies of RNA-Seq datasets |
| Q37326719 | Expression analysis and in silico characterization of intronic long noncoding RNAs in renal cell carcinoma: emerging functional associations |
| Q58712424 | Female mice lacking Ftx lncRNA exhibit impaired X-chromosome inactivation and a microphthalmia-like phenotype |
| Q37213000 | Female mice lacking Xist RNA show partial dosage compensation and survive to term |
| Q38231209 | Functional significance of long non-coding RNAs in breast cancer. |
| Q47819316 | Gene regulation of mammalian long non-coding RNA. |
| Q34144687 | Genetic and pharmacological reactivation of the mammalian inactive X chromosome. |
| Q34038562 | Genome-wide mapping and characterization of Notch-regulated long noncoding RNAs in acute leukemia |
| Q37167313 | Guided by RNAs: X-inactivation as a model for lncRNA function. |
| Q34245929 | Haploid genomes illustrate epigenetic constraints and gene dosage effects in mammals |
| Q37604320 | High Expression of LINC01420 indicates an unfavorable prognosis and modulates cell migration and invasion in nasopharyngeal carcinoma |
| Q37524878 | High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. |
| Q34208023 | Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice |
| Q26863298 | HypoxamiRs and cancer: from biology to targeted therapy |
| Q34485787 | Identification of Spen as a Crucial Factor for Xist Function through Forward Genetic Screening in Haploid Embryonic Stem Cells. |
| Q36115147 | Impact of flanking chromosomal sequences on localization and silencing by the human non-coding RNA XIST. |
| Q37406825 | Increased expression of long non-coding RNA XIST predicts favorable prognosis of cervical squamous cell carcinoma subsequent to definitive chemoradiation therapy |
| Q38902420 | Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer |
| Q90733980 | Involvement of X-chromosome Reactivation in Augmenting Cancer Testis Antigens Expression: A Hypothesis |
| Q38878851 | JAK-STAT signaling in cancer: From cytokines to non-coding genome. |
| Q36004601 | Junk DNA and the long non-coding RNA twist in cancer genetics. |
| Q90427390 | LINC00565 promotes proliferation and inhibits apoptosis of gastric cancer by targeting miR-665/AKT3 axis |
| Q64245246 | LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway |
| Q33986195 | LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia |
| Q37655035 | Lineage and species-specific long noncoding RNAs during erythro-megakaryocytic development |
| Q52357053 | LncKdm2b controls self-renewal of embryonic stem cells via activating expression of transcription factor Zbtb3. |
| Q36189779 | LncRNA BCAR4 wires up signaling transduction in breast cancer |
| Q47217934 | LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. |
| Q103836647 | LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis |
| Q33624404 | Long Coding RNA XIST Contributes to Neuronal Apoptosis through the Downregulation of AKT Phosphorylation and Is Negatively Regulated by miR-494 in Rat Spinal Cord Injury |
| Q90662671 | Long Non-Coding RNA Plasmacytoma Variant Translocation 1 (PVT1) Enhances Proliferation, Migration, and Epithelial-Mesenchymal Transition (EMT) of Pituitary Adenoma Cells by Activating β-Catenin, c-Myc, and Cyclin D1 Expression |
| Q38450930 | Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia |
| Q90403271 | Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia |
| Q36405508 | Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering Glycolysis |
| Q59810444 | Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway |
| Q36796798 | Long Noncoding RNAs in Cancer Pathways |
| Q38641303 | Long Noncoding RNAs in Cancer and Therapeutic Potential. |
| Q28083390 | Long Noncoding RNAs: A New Regulatory Code in Metabolic Control |
| Q39134094 | Long Noncoding RNAs: At the Intersection of Cancer and Chromatin Biology |
| Q59127295 | Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA |
| Q92993245 | Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome |
| Q92604789 | Long non-coding RNA NEAT1 modulates hypoxia/reoxygenation-induced cardiomyocyte injury via targeting microRNA-520a |
| Q35844784 | Long non-coding RNA ROR decoys gene-specific histone methylation to promote tumorigenesis. |
| Q42378706 | Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis |
| Q37251389 | Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression |
| Q38188450 | Long non-coding RNA in health and disease |
| Q37137692 | Long non-coding RNAs and their implications in cancer epigenetics. |
| Q39356241 | Long non-coding RNAs control hematopoietic stem cell function |
| Q62083228 | Long non-coding RNAs in cancer: implications for personalized therapy |
| Q64922153 | Long non-coding RNAs in hematopoietic regulation. |
| Q28070169 | Long non-coding RNAs in normal and malignant hematopoiesis |
| Q33585055 | Long non-coding RNAs in stem cells and cancer |
| Q90274816 | Long non-coding RNAs regulate drug resistance in cancer |
| Q34389273 | Long non-coding RNAs: new players in cell differentiation and development |
| Q38966959 | Long noncoding RNA (lincRNA), a new paradigm in gene expression control |
| Q41167331 | Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer. |
| Q47138459 | Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. |
| Q36959100 | Long noncoding RNAs and the genetics of cancer. |
| Q33624959 | Long noncoding RNAs during normal and malignant hematopoiesis |
| Q36928312 | Long noncoding RNAs in biology and hematopoiesis. |
| Q36353705 | Long noncoding RNAs in cancer: from function to translation |
| Q36422024 | Long noncoding RNAs in diseases of aging |
| Q26742057 | Long noncoding RNAs in hematopoiesis |
| Q46191604 | Long noncoding RNAs in hematopoietic malignancies |
| Q37524850 | Long noncoding RNAs: fresh perspectives into the RNA world |
| Q45540633 | Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells. |
| Q50236752 | Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling. |
| Q38159961 | Maintenance of epigenetic information: a noncoding RNA perspective |
| Q91786123 | Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression |
| Q34079434 | Methods for the study of long noncoding RNA in cancer cell signaling |
| Q34592847 | Mice without macroH2A histone variants |
| Q36866382 | MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. |
| Q35538600 | Mitochondrial maintenance failure in aging and role of sexual dimorphism |
| Q93358749 | Modulating the expression of long non-coding RNAs for functional studies |
| Q58573068 | Molecular Moirai: Long Noncoding RNA Mediators of HSC Fate |
| Q64063421 | N-Methyladenosine (mA): A Promising New Molecular Target in Acute Myeloid Leukemia |
| Q49953053 | NKILA inhibits NF-κB signaling and suppresses tumor metastasis. |
| Q92403293 | Network Diffusion Approach to Predict LncRNA Disease Associations Using Multi-Type Biological Networks: LION |
| Q55237582 | Non-Coding Transcript Heterogeneity in Mesothelioma: Insights from Asbestos-Exposed Mice. |
| Q36998286 | Non-coding RNA LINC00857 is predictive of poor patient survival and promotes tumor progression via cell cycle regulation in lung cancer |
| Q35218913 | Non-coding RNA: a new frontier in regulatory biology |
| Q38109600 | Non-coding RNAs in homeostasis, disease and stress responses: an evolutionary perspective |
| Q45793605 | Non-coding RNAs: The cancer X factor. |
| Q38859581 | Noncoding RNA and colorectal cancer: its epigenetic role |
| Q36038586 | Over-expression of XIST, the Master Gene for X Chromosome Inactivation, in Females With Major Affective Disorders |
| Q37642818 | Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer |
| Q64092997 | P-TEFb Regulates Transcriptional Activation in Non-coding RNA Genes |
| Q58782584 | Perturbed maintenance of transcriptional repression on the inactive X-chromosome in the mouse brain after Xist deletion |
| Q56337055 | Pharmacological reactivation of inactive X-linked in cerebral cortical neurons of living mice |
| Q34257602 | Physiological roles of long noncoding RNAs: insight from knockout mice |
| Q60919830 | Pivotal prognostic and diagnostic role of the long non‑coding RNA colon cancer‑associated transcript 1 expression in human cancer (Review) |
| Q38130412 | Potential pathological and functional links between long noncoding RNAs and hematopoiesis |
| Q35535242 | Practical murine hematopathology: a comparative review and implications for research |
| Q39458571 | Probing Long Non-coding RNA-Protein Interactions. |
| Q37642742 | Professor HUANG Sheng-Kai |
| Q38377189 | Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia |
| Q125637276 | RETRACTED ARTICLE: Long non-coding RNA muscleblind like splicing regulator 1 antisense RNA 1 (LncRNA MBNL1-AS1) promotes the progression of acute myocardial infarction by regulating the microRNA-132-3p/SRY-related high-mobility-group box 4 (SOX4) ax |
| Q90267391 | Recent Advances in Understanding the Reversal of Gene Silencing During X Chromosome Reactivation |
| Q92153616 | Relationships of Non-coding RNA with diabetes and depression |
| Q47635276 | Repeat E anchors Xist RNA to the inactive X chromosomal compartment through CDKN1A-interacting protein (CIZ1). |
| Q91928822 | Reverse-genetics studies of lncRNAs-what we have learnt and paths forward |
| Q38136969 | Role of long non-coding RNAs in normal and malignant hematopoiesis |
| Q90274839 | Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance |
| Q38761159 | Roles for long non-coding RNAs in physiology and disease. |
| Q26765422 | Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer |
| Q52659475 | Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation. |
| Q38808593 | Sexual dimorphism in cancer |
| Q34924833 | Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming |
| Q33410496 | Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3) |
| Q36453395 | Systematic Analysis of Sex-Linked Molecular Alterations and Therapies in Cancer |
| Q36434936 | TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes |
| Q26750498 | The "lnc" between 3D chromatin structure and X chromosome inactivation |
| Q89667139 | The B-side of Xist |
| Q47101298 | The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs |
| Q33599755 | The More the Merrier-Complexity in Long Non-Coding RNA Loci |
| Q92137481 | The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia |
| Q89129149 | The Role of Xist in X-Chromosome Dosage Compensation |
| Q33746465 | The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes |
| Q21246017 | The basal transcription machinery as a target for cancer therapy |
| Q38915010 | The bright side of dark matter: lncRNAs in cancer |
| Q38972951 | The crosstalk between long non-coding RNAs and PI3K in cancer |
| Q38163480 | The dynamics of X-chromosome inactivation in mouse development |
| Q38626016 | The emerging role of lncRNAs in cancer |
| Q38949273 | The emerging role of long non-coding RNAs in cutaneous melanoma |
| Q35238263 | The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer |
| Q22000593 | The lncRNA Firre anchors the inactive X chromosome to the nucleolus by binding CTCF and maintains H3K27me3 methylation |
| Q37688758 | The lncRNA XIST exhibits oncogenic properties via regulation of miR-449a and Bcl-2 in human non-small cell lung cancerThis article has been corrected since Advanced Online Publication, and an erratum is also printed in this issue |
| Q61796082 | The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells |
| Q38218971 | The mechanistic role of DNA methylation in myeloid leukemogenesis |
| Q41331438 | The non-coding RNA landscape of human hematopoiesis and leukemia. |
| Q33763595 | The nuclear matrix protein CIZ1 facilitates localization of Xist RNA to the inactive X-chromosome territory |
| Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
| Q49596604 | The role of long non-coding RNAs in rheumatic diseases. |
| Q85931089 | Tumor Ulceration Does Not Fully Explain Sex Disparities in Melanoma Survival among Adolescents and Young Adults |
| Q37550949 | Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias |
| Q38712988 | Turning the tide in myelodysplastic/myeloproliferative neoplasms |
| Q42088141 | U2AF1 mutations alter splice site recognition in hematological malignancies |
| Q36802536 | Unusual maintenance of X chromosome inactivation predisposes female lymphocytes for increased expression from the inactive X |
| Q87873955 | Utx loss causes myeloid transformation |
| Q57040730 | Whole-exome sequencing capture kit biases yield false negative mutation calls in TCGA cohorts |
| Q89636577 | Widespread organ tolerance to Xist loss and X reactivation except under chronic stress in the gut |
| Q33729692 | X Chromosome of female cells shows dynamic changes in status during human somatic cell reprogramming |
| Q35116343 | X chromosome inactivation: recent advances and a look forward |
| Q36396148 | X chromosome reactivation in reprogramming and in development |
| Q33982880 | X chromosome regulation: diverse patterns in development, tissues and disease |
| Q34620863 | X marks the spot: does it matter that O-GlcNAc transferase is an X-linked gene? |
| Q36782721 | X-chromosome inactivation and escape |
| Q38220878 | X-chromosome inactivation in development and cancer. |
| Q48362806 | X-inactive specific transcript RNA in-situ hybridization as a tool for resolving specimen contamination events. |
| Q47552076 | X-inactive-specific transcript of peripheral blood cells is regulated by exosomal Jpx and acts as a biomarker for female patients with hepatocellular carcinoma |
| Q58797486 | XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p |
| Q92084159 | Xist Deletional Analysis Reveals an Interdependency between Xist RNA and Polycomb Complexes for Spreading along the Inactive X |
| Q35738090 | Xist Exon 7 Contributes to the Stable Localization of Xist RNA on the Inactive X-Chromosome. |
| Q90180450 | Xist RNA in action: Past, present, and future |
| Q41090643 | Xist RNA repeat E is essential for ASH2L recruitment to the inactive X and regulates histone modifications and escape gene expression. |
| Q37536541 | Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression. |
| Q88150054 | [Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia] |
| Q37204601 | p120catenin alteration in cancer and its role in tumour invasion. |
| Q38759968 | p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity |
Search more.